ADVANCED HEART FAILURE THERAPIES: FOCUS ON CARDIAC TRANSPLANTATION

Saturday, March 8, 2025

10:30 AM – 12:00 PM ET

Moderator(s)

Samer Najjar, MD

Regional Chief of Cardiology (Baltimore)
MedStar Health
Baltimore, Maryland, United States

Disclosure(s): No financial relationships to disclose
Sean P. Pinney, MD

Chief of Cardiology, Mount Sinai Morningside
Icahn School Of Medicine At Mount Sinai Morningside/West
New York, New York, United States

Disclosure(s): Abbott Labs: Consultant (Ongoing); Analog Devices Inc: Consultant (Ongoing); Ancora Heart: Consultant (Ongoing); CareDx: Consultant (Ongoing); Cordio Medical: Consultant (Ongoing); Medtronic: Consultant (Ongoing); Nuwellis: Consultant (Ongoing); Restore Medical: Consultant (Ongoing); TransMedics (Organ Transplant ) TMDX : NASDQ: Consultant (Ongoing), Stock-publicly held company (excluding mutual/index funds) (Ongoing); Valgen Medtech: Consultant (Ongoing)

Disclosure(s):

Samer Najjar, MD: No financial relationships to disclose

Sean P. Pinney, MD: Abbott Labs: Consultant (Ongoing); Analog Devices Inc: Consultant (Ongoing); Ancora Heart: Consultant (Ongoing); CareDx: Consultant (Ongoing); Cordio Medical: Consultant (Ongoing); Medtronic: Consultant (Ongoing); Nuwellis: Consultant (Ongoing); Restore Medical: Consultant (Ongoing); TransMedics (Organ Transplant ) TMDX : NASDQ: Consultant (Ongoing), Stock-publicly held company (excluding mutual/index funds) (Ongoing); Valgen Medtech: Consultant (Ongoing)